The adverse effects of oral anticoagulant therapy (OAT) are the main cause of
hospitalization for drug accidents, and most of them could be avoided by more rigorous …

The clinical management of individuals with hereditary hypercoaguable disorders has
evolved from initial broad recommendations of lifelong anticoagulation after first event of …

The impact of prothrombotic abnormalities on the risk of recurrent venous thromboembolism
(VTE) and bleeding in patients receiving long‐term anticoagulation remains unclear. This …

Chronic anticoagulant therapy with vitamin K antagonists (eg, warfarin) requires temporary
interruption before surgery because anticoagulation is associated with excessive operative …

Dear Sir, Whether the Marburg I variant of factor VII-activating protease (FSAP Marburg I) is
associated with an increased risk of venous thromboembolism (VTE) is still an open …

Objective Recurrent thromboembolic events may occur after termination of anticoagulant
therapy for acute venous thromboembolism (VTE) using oral direct thrombin inhibitor …

Warfarinbehandling i allmennpraksis | Tidsskrift for Den norske legeforening Hopp til
hovedinnhold Veksle navigasjon Artikler Fagområder Utgaver Podkast Forfatterveiledning …

The acquired hypercoagulable states are responsible for a broad range of thrombotic and
thromboembolic disorders. Symptoms and signs of acute ischemia or organ dysfunction will …

Oral anticoagulants (OAs) are the drugs of choice for the prevention of recurrence and death
in patients with venous thromboembolism (VTE). Oral anticoagulant treatment (OAT) aims to …

The field of venous thromboembolism (VTE) has seen tremendous growth since the last
edition of the “Venous Thromboembolism Guidebook.” This fifth edition incorporates …